AMSBIO has announced a
package of initiatives to support the Glycobiology research community following
the recent announcement by Seikagaku Corporation that they plan to discontinue
their research reagents and glycobiology biochemicals business as of September
30th 2011.
As a specialist in high purity reagents for glycobiology and glycoanalysis for
over 20 years - AMSBIO has developed in-depth technical expertise and a broad
range of products including a unique range of antibodies, enzymes, assays and
standards for Proteoglycan and Glycosaminoglycan (GAG) research.
Alex Sim, CEO of AMSBIO commented "To support users of Seikagaku research
reagents, GAG antibodies and biochemicals, we have invested in inventory to
enable us to supply researchers for the next 18-24 months". He added
"In addition we are actively working on alternative products and to
maintain our global reputation as being the premier supplier for Glycobiology
research".
For further information on high purity reagents for glycobiology and
glycoanalysis please visit
www.proteoglycan.info
or contact AMSBIO on telephone +44-1235-828200 / email
WilliamB@amsbio.com.
Founded in 1987, AMS Biotechnology (amsbio) is recognized as a leading
international provider of unique & innovative products & custom
services for life sciences research. The amsbio range includes over 23,000
polyclonal & monoclonal antibodies, peptides, recombinant proteins,
extracellular matrix, molecular detection reagents, & tissue DNA, RNA,
protein & microarray products. Key research areas include: apoptosis, cell
invasion & migration, cell signaling, DNA damage, electrophoresis,
glycobiology, post translational modification and stem cell biology.
